CINA CHEST vs Bunkerhill MAC

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CINA CHEST

by Avicenna.AI

Bunkerhill MAC

by Bunkerhill Health

AI Verdict

CINA CHEST is an AI tool focused on the rapid detection and triage of acute, life-threatening conditions such as Pulmonary Embolism and Aortic Dissection from CT angiography scans. In contrast, Bunkerhill MAC specializes in detecting and quantifying mitral annular calcification on routine CT scans to identify long-term cardiovascular risk and support care coordination. While both operate within cardiology and radiology AI, they address distinct clinical needs: acute emergency triage versus chronic risk assessment and management.

Choose CINA CHEST if…

Choose CINA CHEST if your primary need is rapid, AI-powered triage and notification for acute, life-threatening chest conditions in an emergency setting. This tool is ideal for emergency departments and radiology workflows where immediate detection and prioritization of Pulmonary Embolism or Aortic Dissection on CT angiography scans are critical for patient outcomes. It helps streamline the identification of urgent cases, allowing for faster intervention.

View CINA CHEST →

Choose Bunkerhill MAC if…

Choose Bunkerhill MAC if your goal is to proactively identify patients at increased cardiovascular risk by detecting and quantifying mitral annular calcification on routine CT scans. This solution is best suited for integrating into existing clinical workflows to support early risk stratification, automated follow-up, and care coordination within a broader cardiovascular health management program. It leverages non-gated chest CTs to uncover long-term risk factors.

View Bunkerhill MAC →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CINA CHEST	Bunkerhill MAC
Pricing	Subscription-based	Unknown
Deployment	Cloud-based, On-premise (dedicated hardware), Virtualized (VM, Docker)	Cloud-based, integrates with EHRs.
BAA Available	Unknown	Yes AI-estimated
FDA Status	K210237 AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CINA CHEST

Tool A (CINA CHEST) operates as a 'standalone web application', suggesting a direct and focused user interface for radiologists. This approach likely offers a simpler and quicker learning curve for its specific triage function. Tool B (Bunkerhill MAC), while offering 'seamless integration with existing EHRs and clinical systems', might involve a more complex initial setup within existing workflows.

Clinical Value

CINA CHEST

Tool A (CINA CHEST) is designed for the 'rapid detection and prioritization of Pulmonary Embolism (PE) and Aortic Dissection (AD)', which are acute, life-threatening conditions requiring immediate intervention. Tool B (Bunkerhill MAC) focuses on detecting and quantifying 'mitral annular calcification (MAC)' for early cardiovascular risk identification, which, while important, addresses a chronic condition and does not typically demand the same urgent, life-saving response.

Pricing & Value

Tie

Both tools lack transparent pricing details in the provided information. Tool A (CINA CHEST) is 'subscription-based; details available upon request,' while Tool B (Bunkerhill MAC) simply states 'contact for pricing.' Without specific figures or models, it is not possible to determine a winner in this dimension.

Enterprise Readiness

CINA CHEST

Tool A (CINA CHEST) offers flexible deployment options including 'Cloud-based, On-premise (dedicated hardware), Virtualized (VM, Docker)' and explicitly states 'hipaa_compliant: yes' with an 'fda_clearance: k210237'. Tool B (Bunkerhill MAC) is 'Cloud-based, integrated with existing EHRs', but its HIPAA compliance and BAA status are only 'likely, but not explicitly stated,' making Tool A's offerings more robust and transparent for enterprise adoption.

Innovation

Bunkerhill MAC

While both utilize AI, Tool B (Bunkerhill MAC) explicitly highlights 'Generative AI for clinical reasoning and action' and its integration with the 'Carebricks generative AI platform'. This suggests a more advanced application of AI beyond simple detection and triage, aiming for broader clinical decision support and automated workflows, which represents a higher degree of innovation.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offered specific details regarding the level of support, availability of comprehensive documentation, or service level agreements for either CINA CHEST or Bunkerhill MAC. Therefore, it is not possible to distinguish a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CINA CHEST	Bunkerhill MAC
Name	CINA CHEST	Bunkerhill MAC
Company	Avicenna.AI	Bunkerhill Health
Primary Detection Focus	Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans	Mitral Annular Calcification (MAC) on routine CT scans
Integration/Platform	Operates as a standalone web application	Integrates with the Carebricks generative AI platform for clinical reasoning and action; seamless integration with existing EHRs and clinical systems
Key AI Functionality	Radiological computer-aided triage and notification; Flags and communicates suspected positive findings	AI-powered detection and quantification of Mitral Annular Calcification (MAC); Supports automated workflows for follow-up and care coordination

Videos

Demos, reviews, and walkthroughs featuring CINA CHEST and Bunkerhill MAC.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of each tool?

CINA CHEST is designed for the rapid detection and prioritization of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans, assisting in emergency radiology triage. Bunkerhill MAC detects and quantifies mitral annular calcification (MAC) on routine CT scans, aiding early cardiovascular risk identification and care coordination.

What types of imaging scans does each tool analyze?

CINA CHEST analyzes Chest and Thoraco-abdominal CT angiography scans for PE and AD. Bunkerhill MAC analyzes routine, non-gated chest CT scans for the detection and quantification of Mitral Annular Calcification (MAC).

How do these tools integrate into existing clinical workflows and systems?

CINA CHEST operates as a standalone web application and offers cloud-based, on-premise, or virtualized deployment, providing notifications with compressed preview images. Bunkerhill MAC is cloud-based and integrates with existing EHRs and clinical systems via the Carebricks platform, supporting automated workflows for follow-up and care coordination.

What specific conditions or markers does each AI tool identify?

CINA CHEST detects Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography. Bunkerhill MAC identifies and quantifies Mitral Annular Calcification (MAC) on routine CT scans.

What are the differences in their FDA clearances?

CINA CHEST has FDA clearance K210237 for the detection and triage of PE and AD. Bunkerhill MAC has received 510(k) FDA clearance as the first AI model authorized to identify and quantify mitral annular calcification on routine CT scans.